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duction in dinoflagellates." Whatever is
plaguing the St. Lucie fish appears to act by
destroying the protective mucous coat of
the fish, inviting opportunistic bacterial and
fungal infections.
Burkholder, Steidinger, and other
researchers are scrambling to determine
whether crypto is indeed toxic, and to solve
the mystery of the sickened fish. "It's
extremely important from a public health
perspective to know what's out there, what
are its toxins and their effects," Steidinger
says. Sometime this summer, researcher
Peter Moeller, project leader for the marine
biotoxins program at the National Ocean
Service in Charleston, South Carolina,
expects to have preliminary results ofbioas-
says he's conducting to determine crypto's
toxins. His findings should aid in under-
standing both crypto and its cousins.
According to Daniel Baden, director of
the NIEHS Marine and Freshwater
Biomedical Sciences Center at the
University of Miami in Florida, three tox-
ins have been associated with Pfiesteria-like
dinoflagellates-a lipid-soluble lethal
toxin, a water-soluble suspected neurotox-
in, and a dermonecrotic toxin. Baden spec-
ulates that lesions found on fish killed by
Pfiesteria may actually be caused by crypto.
"People have been working with mixed
cultures," he says, "but because the organ-
isms were differentiated only recently, we
haven't had time to ascribe specific toxins
to specific organisms."
Some researchers hope to ward off
future outbreaks by determining what
caused an ancient species of microalgae to
strike here and now. "We believe crypto has
been here hundreds, maybe thousands of
years," says DEP marine biologist Ann
Forstchen. Four times over the last 20 years,
the St. Lucie Estuary has suffered outbreaks
of fish disease. Each followed unusually
high discharges from the St. Lucie Canal
into the St. Lucie River, in which the South
Florida Water Management District flushed
fresh water from Lake Okeechobee through
the canal to prevent flooding. "There's an
apparent causal relationship between mas-
sive discharges and the outbreak of ulcers,"
says Dan Haunert, a lead scientist with the
South Florida Water Management District.
Nutrient runoffinto the canal is believed to
promote microalgal growth while the force
of the discharges is thought to push the
growth up from the bottom sediment.
Although studies are incomplete, crypto
appears to have little, if any, effect on
humans. Two months into the St. Lucie
outbreak, the Florida Department ofHealth
had received fewer than tWO dozen com-
plaints from people who suspected they had
been harmed by contact with the river
water. "We haven't seen a
clear association between
exposure and illness," says
epidemiologist Alan
Rowan. "[People are]
reporting various symp-
toms and they've had a
wide range of exposures,
from one day to five years.
There may be alternative
explanations."
New water worries. Cryptoperidiniopsis, a species of microalgae, may
be causing sick fish-and concerns for human health.
As freshwater discharges dropped off in
April, so did the number of diseased fish
brought to the DEP's trailer outside the
Snook Nook. Scientists believe the fish dis-
ease event may have run its course. But
Forstchen expects it to return, just as she
expects the periodic return of unseasonably
heavy rains. "I don't thinkwe'll be in a posi-
tion to stop [outbreaks]," she says, "but we
maybeable to predictwhen they'll happen."
Lasers for Lungs
Lung cancer is one of the deadliest cancers
in the United States, striking an estimated
190,000 people and killing 160,000 annu-
ally. Smoking is the major cause of lung
cancer worldwide,but asbestos, air pollu-
tion, and radon appear to contribute to this
disease. By the time cancers of the lung
become visible through conventional diag-
nostics, they frequently are too far advanced
to treat successfully. Now, Xillix
Technologies Corporation of Richmond,
British Columbia, has developed a technol-
ogy that allows much earlier diagnosis of
these dangerous cancers, possibly helping to
save lives. The device was approved by the
U.S. Food and DrugAdministration (FDA)
for use on lung cancers on 20 September
1996.
The lethal nature ofnon-small cell lung
cancer (NSCLC) lies largely in the fact that,
by the time the tumor becomes visible to
the oncologist, it has spread too widely to
be successfully surgically removed or irradi-
ated. Chemotherapy also has had very limit-
ed success against lung cancer. Sixty-five
percent ofstage I cancers, 50-55% ofstage
II cancers, and 30% ofstage III cancers are
cured. But most lung cancers are not caught
until stage 3 or 4, says Tracy Lee Weigel, an
assistant professor ofsurgery and director of
the LIFE-Lung Bronchoscopy Program at
the University of Pittsburg School of
Medicine in Pennsylvania. For all those
diagnosed with NSCLC, she says, the five-
year survival rate is about 13-14%.
The new technology, which Xillix calls
the Lung Imaging Fluorescence Endoscopy
bronchoscopic system, or LIFE-Lung, helps
doctors detect lung cancers 1-2 years earlier
than standard bronchoscopy, says Weigel.
This can make all the difference in catching
the disease in time. "We can [detect lung
cancers] before they've broken through the
basement membrane [of the lung], before
they've gained access to the lymphatics and
the bloodstream and develop the potential
to metastasize," she says.
The LIFE-Lung works according to sim-
ple principals. Tissue fluoresces when illu-
minatedwith laser light, but the autofluores-
cent properties ofnormal and malignant tis-
sues differ. A physician uses the LIFE-Lung
bronchoscope-a laser hooked to a flexible
fiberoptic endoscope-to shine light onto
the lungs through the fiberoptic imaging
bundle ofthe scope. The fluorescence given
offby the illuminated tissue is relayed back
through a second imaging bundle and
observed directly by the physician. With the
LIFE-Lung, healthy lung tissue appears
green and abnormal tissue appears red. In
clinical trials, the LIFE-Lung was "171%
more sensitive in picking up abnormalities
than white light," says Harvey Pass, aprofes-
sor ofsurgery and oncology at Wayne State
University in Detroit, Michigan, and pro-
gram director for the Barbara Ann
Karmanos Cancer Institute in Detroit. A
similar device, which uses a computer algo-
rithm to distinguish between the subtle dif-
ferences in the wavelengths of fluorescent
light given offby normal and malignant tis-
sues, is in development at Oak Ridge
National Laboratory in Tennessee.
Differential fluorescence does not
replace biopsy, says Bergein F. Overholt,
president of Gastrointestinal Associates in
Knoxville, Tennessee, a company involved
in the development of the Oak Ridge
A 426 Volume 106, Number 9, September 1998 * Environmental Health PerspectivesForum
device, but it may help decrease the number
of biopsies needed by allowing a physician
to screen large swaths oftissue quickly, and
guiding them to sites of malignancies.
Biopsy, which is still necessary for confirma-
tion ofmalignancy, becomes much less ofa
hit-or-miss proposition with the use of the
LIFE-Lung.
Weigel asserts that differential fluores-
cence is currently too expensive to be practi-
cal for general screening. She estimates the
cost of the procedure at $2,000, compared
to the $40 cost ofa chest X-ray, the current
general screening method. She is testing the
technique in the highest-risk patients: peo-
ple who appear to be cured following suc-
cessful resection of lung cancer but who
have approximately a 5% annual chance of
developing a second primary cancer, and
people with emphysema, who have a 3-5%
annual chance ofdevelopinglung cancer.
One ofthe biggest contributions differ-
ential fluorescence can make, says Weigel,
is to render practical a new technique called
photodynamic therapy. The 30-minute
procedure begins 48 hours after injection of
a photosensitized drug, Photofrin, which
concentrates mainly in cancerous tissue.
When activated by nonthermal, 630-nm
red laser light, Photofrin destroys cancer
cells, leaving healthy tissue relatively
unharmed. "Photodynamic therapy is cura-
tive in over 90% of patients with early
NSCLC," says Weigel. "The importance of
differential fluorescence for photodynamic
therapy is that it could tell the oncologist
where to shine the laser to kill the cancer so
that they are not, in effect, shooting in the
dark." Photodynamic therapy was condi-
tionally approved for treatment of early
stage I lung cancers by the FDA in January
1998.
Weigel also thinks differential fluores-
cence will become useful for monitoring
treatment ofcancers to make sure the treat-
ment is working. Doctors would simply use
the device on patients who have undergone
radiation orphotodynamic therapyto make
sure the cancer had disappeared.
Both Xillix and Oak Ridge National
Laboratory are developing differential fluo-
rescence to screen a wide variety of other
cancers, notably ofthe gastrointestinal tract.
Oak Ridge researchers successfully tested
their device against esophageal cancer, a rare
but increasing malignancy that afflicts
11,000 and kills 10,000 people in the
United States annually. In clinical trials,
specificity was 95-100%, says Overholt.
Xillix also plans to target bladder cancer,
cervical cancer, and head and neck cancers
with its device, says Laurie McMichael, the
company's manager of investor relations
and communications.
K P e <Disease-free Zone
TheAnimal and Plant Health Inspection Service (APHIS), aservice ofthe U.S. Department
ofAgriculture (USDA), is responsible formaintaining the health ofthe United States' plants
and animals and thereby contributing to the national economy and public health. This
indudes guarding against the importation ofdiseases and pests, controlling insect and plant
diseases thatdo breakoutwithin thenation's borders, andprovidingprotection forU.S. ani-
mals ranging from endangered wild species to laboratory rats to show dogs. The APHIS
WorldWide Web site, located at http:/lwww.aphis.usda.govl, offers some insight into how
theservice discharges itsresponsibilities.
The Mission linkon the main page leads to a narrative, pepperedwith hypertext, that
describes the mission ofthe APHIS and how the service goes about carrying out its mis-
sion. Each link within the narrative
leads to fact sheets and APHIS pro-
gram pages, such as the Center for
Veterinary Biologics home page, the
National Biological Control Institute
home page, and a fact sheet on how
APHIS facilitates the safe export of
agricultural products. The Activities
link leads to a guided tour ofAPHIS's activities conveyed through pictures. The
Organization linkleads to an easilynavigable table ofthevarious officeswithinAPHIS.
Underthe Functions heading on the main page is alistoflinks to topics ofcarewith-
in the service. Each linkleads to an outline ofkeyAPHIS links, as well as otherWeb sites
related to the topic. For instance, the Exduding Pests link provides access to such sites as
the APHIS Plant Protection and Quarantine home page; the APHIS Welcome to the
United States site, which outlines customs requirements for importing fruits, vegetables,
and plants; and the MeetAgriculture's Beagle Brigade! site, which tells how the USDA is
using beagles to sniffout illegal fruit and meat arriving from overseas. Related Web sites
listed under the Exduding Pests linkinclude the home pages for the U.S. Customs Service
andthe U.S. Immigration andNaturalization Service.
The News & Information heading on the main page is the gateway to a wealth of
information on such topics as APHIS publications, regulations, import-export rules, and
congressional statements. The Publications link leads to a listing ofall currently available
APHIS publications, avast library ofbrochures, fact sheets, and technical reports on topics
ranging from the Africanized honeybee to water spinach. The Regulations link leads to a
bank ofallAPHIS documents publishedwithin the past four months, as well as an archive
ofFederalRegister notices dating back to 1995. This link also leads to a searchable online
version ofthe 1998 edition ofthe CodeofFederalRegulations.
The Import-Export link found under the News & Information heading leads to a
detailed listing ofthe rules on importing and exporting various plant and animal species
and products. The listing succinctly describes the documentation that must accompany
each import or export, and includes contact telephone numbers for more information
about specific families ofplants and animals. The Communications to Congress link on
the main page leads to the most recent statements and reports presented before Congress
byAPHIS, such as a 20 May 1998 statement byAPHIS acting administrator Craig Reed
concerning the Plant ProtectionAct.
The Hot Issues heading on the main page covers links to plant and animal issues in
the headlines. For instance, the Medflies in Florida link leads to updates on how various
Florida counties are faring in the battle against the Mediterranean fruit fly, which threat-
ens the state's agriculture industry (the state is releasing sterile fruit flies as well as applying
the pesticide malathion in an effort to eradicate the imported pest). Another example is
the Vesicular Stomatitis link, which leads to weekly updates and contact information
regarding the outbreak of this viral disease that appeared among New Mexico horses in
mid-May.
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